Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

$90.7M

Market Cap • 12/20/2024

2002

(22 years)
Founded

2019

(5 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Vista

Headquarters • California